DD202580A5 - Verfahren zur herstellung von 6 alpha-methylhydrocortison-derivaten - Google Patents

Verfahren zur herstellung von 6 alpha-methylhydrocortison-derivaten Download PDF

Info

Publication number
DD202580A5
DD202580A5 DD81235958A DD23595881A DD202580A5 DD 202580 A5 DD202580 A5 DD 202580A5 DD 81235958 A DD81235958 A DD 81235958A DD 23595881 A DD23595881 A DD 23595881A DD 202580 A5 DD202580 A5 DD 202580A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
dione
pregnene
hydroxy
dihydroxy
Prior art date
Application number
DD81235958A
Other languages
German (de)
English (en)
Inventor
Klaus Annen
Karl Petzoldt
Henry Laurent
Rudolf Wichert
Helmut Hofmeister
Hans Wendt
Manfred Albring
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD202580A5 publication Critical patent/DD202580A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Cephalosporin Compounds (AREA)
DD81235958A 1980-12-23 1981-12-18 Verfahren zur herstellung von 6 alpha-methylhydrocortison-derivaten DD202580A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3049400 1980-12-23

Publications (1)

Publication Number Publication Date
DD202580A5 true DD202580A5 (de) 1983-09-21

Family

ID=6120491

Family Applications (2)

Application Number Title Priority Date Filing Date
DD81248374A DD208812A5 (de) 1980-12-23 1981-12-18 Verfahren zur herstellung von 6-alpha-methylhydrocortison-derivaten
DD81235958A DD202580A5 (de) 1980-12-23 1981-12-18 Verfahren zur herstellung von 6 alpha-methylhydrocortison-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD81248374A DD208812A5 (de) 1980-12-23 1981-12-18 Verfahren zur herstellung von 6-alpha-methylhydrocortison-derivaten

Country Status (26)

Country Link
US (1) US4912098A (xx)
EP (1) EP0054786B1 (xx)
JP (1) JPS57167999A (xx)
AT (1) ATE12237T1 (xx)
AU (1) AU548999B2 (xx)
BG (2) BG38337A3 (xx)
CA (1) CA1185234A (xx)
CS (5) CS221781A2 (xx)
DD (2) DD208812A5 (xx)
DE (1) DE3169460D1 (xx)
DK (1) DK159324C (xx)
ES (3) ES8307896A1 (xx)
FI (1) FI72729C (xx)
GB (1) GB2089809B (xx)
GR (1) GR76975B (xx)
HU (1) HU186460B (xx)
IE (1) IE52511B1 (xx)
IL (1) IL64614A (xx)
NO (1) NO156409C (xx)
PH (1) PH17637A (xx)
PL (5) PL238738A1 (xx)
PT (1) PT74183B (xx)
RO (1) RO83669B (xx)
SU (2) SU1245264A3 (xx)
YU (5) YU293181A (xx)
ZA (1) ZA818907B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133081A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
DE3427486A1 (de) * 1984-07-23 1986-01-30 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 6(alpha)-methylsteroiden
CN102401624B (zh) * 2010-09-10 2014-07-16 珠海格力电器股份有限公司 步进电机行程位置检测装置及检测控制方法
CN102964414A (zh) * 2012-12-14 2013-03-13 中国科学院上海有机化学研究所 17位甾体羧酸酯的合成方法
EP3006453A1 (en) * 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141876A (en) * 1956-08-02 1964-07-21 Upjohn Co 3-keto-6-methyl-4-pregnene-3, 20-diones and a method for the production thereof
US3176032A (en) * 1958-04-18 1965-03-30 Syntex Corp 17alpha, 21-diacyloxy derivatives of 6alpha-methyl-delta1, 4-pregnadien-3, 20-dione and of 6alpha-methyl-delta4-pregnen-3, 20-dione
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
DE2848423A1 (de) * 1978-11-08 1980-05-29 Merck Patent Gmbh Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB2089809B (en) 1984-09-26
CS231198B2 (en) 1984-10-15
ES8401988A1 (es) 1984-01-16
NO156409B (no) 1987-06-09
BG38337A3 (en) 1985-11-15
CS8109720A2 (en) 1984-02-13
YU103283A (en) 1983-10-31
PT74183B (de) 1983-05-18
GB2089809A (en) 1982-06-30
ES8302027A1 (es) 1983-02-01
ZA818907B (en) 1982-11-24
CS221981A2 (en) 1984-02-13
HU186460B (en) 1985-08-28
PL234367A1 (en) 1983-02-28
PL238739A1 (en) 1983-05-09
IL64614A0 (en) 1982-03-31
FI72729C (fi) 1987-07-10
DK159324C (da) 1991-02-25
BG38338A3 (en) 1985-11-15
DK571981A (da) 1982-06-24
RO83669B (ro) 1984-08-30
ES508325A0 (es) 1983-08-01
JPH0257559B2 (xx) 1990-12-05
NO156409C (no) 1987-09-30
GR76975B (xx) 1984-09-04
ATE12237T1 (de) 1985-04-15
AU548999B2 (en) 1986-01-09
DE3169460D1 (en) 1985-04-25
ES510339A0 (es) 1983-02-01
US4912098A (en) 1990-03-27
EP0054786B1 (de) 1985-03-20
IE52511B1 (en) 1987-11-25
JPS57167999A (en) 1982-10-16
YU102083A (en) 1983-10-31
ES8307896A1 (es) 1983-08-01
CA1185234A (en) 1985-04-09
YU103383A (en) 1983-12-31
AU7854981A (en) 1982-07-01
CS231199B2 (en) 1984-10-15
PL130894B1 (en) 1984-09-29
EP0054786A1 (de) 1982-06-30
NO814394L (no) 1982-06-24
FI814126L (fi) 1982-06-24
PL238741A1 (en) 1983-05-09
CS231197B2 (en) 1984-10-15
DD208812A5 (de) 1984-04-11
PL238740A1 (en) 1983-05-09
CS221883A2 (en) 1984-02-13
PL238738A1 (en) 1983-05-09
IL64614A (en) 1985-06-30
DK159324B (da) 1990-10-01
YU293181A (en) 1983-10-31
PT74183A (de) 1982-01-01
PL130895B1 (en) 1984-09-29
CS222081A2 (en) 1984-02-13
RO83669A (ro) 1984-06-21
CS231188B2 (en) 1984-10-15
YU103183A (en) 1983-10-31
CS221781A2 (en) 1984-02-13
SU1255053A3 (ru) 1986-08-30
CS231200B2 (en) 1984-10-15
ES521498A0 (es) 1984-01-16
PH17637A (en) 1984-10-18
FI72729B (fi) 1987-03-31
SU1245264A3 (ru) 1986-07-15

Similar Documents

Publication Publication Date Title
EP0072547B1 (de) Neue 6-alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
EP0110041B1 (de) Neue 6alpha-Methylkortikoide, ihre Herstellung und Verwendung
EP0100874A2 (de) Neue 6,16-Dimethylkortikoide, ihre Herstellung und Verwendung
EP0072546B1 (de) Neue Hydrocortison-Derivate, ihre Herstellung und Verwendung
DD202580A5 (de) Verfahren zur herstellung von 6 alpha-methylhydrocortison-derivaten
EP0149222B1 (de) Neue 6alpha, 16alpha-Dimethylkortikoide
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
EP0149464A2 (de) 6-Alpha,16-beta-Dimethylkortikoide
DE1181705B (de) Verfahren zur Herstellung von 16ß-niedrig-Alkylcortisonen, -hydrocortisonen, -prednisonen und -prednisolonen sowie von deren 9 alpha-Halogenderivaten und 21-Estern
DD158778A5 (de) Verfahren zur herstellung halogenierter steroide
DE3621024A1 (de) 11(beta)-phenyl-estrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2839033A1 (de) 3-oxo-4-pregnen-20 alpha -carbonsaeure- derivate, ihre herstellung und verwendung
CH633562A5 (de) Verfahren zur herstellung neuer kortikoide.
CH623062A5 (xx)
DE3409554A1 (de) Neue 6(alpha)-methyl-d-homo-kortikoide
DE2636404C2 (de) Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
EP0144086A2 (de) Neue Hydrocortison- und Prednisolon-Derivate
EP0112467A1 (de) Neue 6alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
CH617709A5 (xx)
EP0078432A1 (de) Neue Kortikoide, ihre Herstellung und Verwendung
DE2753839A1 (de) Neue kortikoide
DE1807980B2 (de) Verfahren zur Herstellung neuer Halogenpregnadiene
DE2656575A1 (de) Neue kortikoide
DE2855465A1 (de) Neue kortikoide, verfahren zu ihrer herstellung, ihre verwendung und diese kortikoide enthaltende pharmazeutische praeparate